IDH1 and central nervous system cancer: This GCIMP mechanism is modulated in IDH-O gliomas, giving rise to a specific GCIMP-O hypermethylation signature that is associated with activated proliferation compared with IDH-A, which is, however, smaller than in IDH-wt gliomas.